Diagnear Health Partners Profile
Key Indicators
- Authorised Capital ₹ 30.00 K
as on 03-11-2024
- Paid Up Capital ₹ 30.00 K
as on 03-11-2024
- Company Age 3 Year, 6 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 559.81%
(FY 2023)
- Profit -252.33%
(FY 2023)
- Ebitda -306.16%
(FY 2023)
- Net Worth -81.59%
(FY 2023)
- Total Assets 64.74%
(FY 2023)
About Diagnear Health Partners
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 K and a paid-up capital of Rs 30.00 K , as per Ministry of Corporate Affairs (MCA) records.
Puneet Vig, Muhammad Shaikh, and Amit Gautam serve as directors at the Company.
- CIN/LLPIN
U85110DL2021PTC391298
- Company No.
391298
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Diagnear Health Partners?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Vig  | Director | 15-Dec-2021 | Current |
| Muhammad Shaikh | Director | 15-Dec-2021 | Current |
| Amit Gautam | Director | 15-Dec-2021 | Current |
Financial Performance of Diagnear Health Partners.
Diagnear Health Partners Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 559.81% increase. The company also saw a substantial fall in profitability, with a 252.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 81.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diagnear Health Partners?
Unlock access to Diagnear Health Partners's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Nexpath Laboratories Private LimitedActive 3 years 22 days
Muhammad Shaikh and Amit Gautam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diagnear Health Partners?
Diagnear Health Partners has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diagnear Health Partners, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diagnear Health Partners's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
